Bacteria in the soil compete for limited resources to survive and proliferate. One of the ways they might do this is by producing antibiotics, but the costs of antibiotic production and their low concentrations in soils have led to uncertainty about the role of these natural products for the bacteria that produce them. Here, we examine the fitness effects of streptomycin production by the filamentous soil bacterium Streptomyces griseus and the conditions that modify its ability to invade competitors. Using pairwise competion assays, we first provide direct evidence that streptomycin production enables S. griseus to kill and invade a population of the susceptible species, S. coelicolor, but not a streptomycin-resistant mutant of this species. Next we show that the fitness benefits of streptomycin production are densitydependent, because production scales positively with cell number, and frequency-dependent, with a threshold of invasion of S. griseus at around 1%. Finally, using serial transfer experiments where spatial structure is either maintained or periodically destroyed, we show that spatial structure reduces the threshold frequency of invasion by more than 100-fold, indicating that antibiotic production can permit invasion from extreme rarity. Our results provide clear evidence that streptomycin is both an offensive and defensive weapon that facilitates invasion into occupied habitats and also protects against invasion by competitors.They also indicate that the benefits of antibiotic production rely on ecological interactions occurring at small local scales, suggesting that low antibiotic concentrations in bulk soil are unlikely to be representative of their effective concentrations in nature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.